Quality of life in patients treated with aflibercept and FOLFIRI for metastatic colorectal cancer: interim analysis with focus on therapy lines of the non -interventional study QoLiTrap (AlO-LQ-0113)

被引：0
|
作者：
Hofheinz, R. [1 ]
Scholten, F. [2 ]
Derigs, H. [2 ]
Thaler, J. [3 ]
von Moos, R. [1 ,4 ]
机构：
[1] Univ Hosp Mannheim, Mannheim, Germany
[2] Klinikum Frankfurt Hoechst GmbH, Frankfurt, Germany
[3] Klinikum Wels Grieskirchen GmbH, Wels, Austria
[4] Kantonsspital Graubuenden, Chur, Switzerland
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD - 026
引用
收藏
页码：118 / 118
页数：1
相关论文
共 50 条
  • [41] Quality of life in a real-world study of patients with metastatic colorectal cancer treated with trifluridine/tipiracil
    Cheung, W. Y.
    Kavan, P.
    Dolley, A.
    CURRENT ONCOLOGY, 2020, 27 (05) : E451 - E458
  • [42] Trifluridine/tipiracil in patients with refractory metastatic colorectal cancer in clinical routine in Germany: Interim results of the non-interventional study TACTIC
    Schwaner, I
    Goehler, T.
    Decker, T.
    Grundeis, M.
    Sauer, A.
    Fichter, C.
    Moorahrend, E.
    Kroening, H.
    Lipke, J.
    Kojouharoff, G.
    Frank, M.
    Hogrefe, C.
    Marschner, N.
    Potthoff, K.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 130 - 131
  • [43] Results From VELOUR, a Phase 3 Study of Aflibercept (A) Versus Placebo (pbo) in Combination with FOLFIRI for the Treatment of Patients (pt) with Previously Treated Metastatic Colorectal Cancer (MCRC)
    Tabernero, J.
    Van Cutsem, E.
    Lakomy, R.
    Prausova, J.
    Ruff, P.
    Van Hazel, G.
    Moiseyenko, V.
    Ferry, D.
    McKendrick, J.
    Soussan-Lazard, K.
    Boelle, E.
    Allegra, C.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : 5 - 5
  • [44] Bevacizumab (Bev)-based combinations across treatment lines in patients (pts) with metastatic colorectal cancer (mCRC) - interim results from a German non-interventional study (KORALLE)
    Eggers, E.
    Uhlig, J.
    Reichert, D.
    Wein, A.
    Schulz, H.
    Beringer, A.
    Arnold, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 162 - +
  • [45] A prospective, randomized study of low molecular weight as supplemental therapy in metastatic colorectal cancer patients treated with FOLFIRI regimen and target agents.
    Tsai, Hsiang-Lin
    Tai, Chi-Jung
    Huang, Ching-Wen
    Wang, Jaw-Yuan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [46] Overall survival and quality of life in patients with metastatic breast cancer treated with nab-paclitaxel: Final results of the non-interventional study NABUCCO
    Potthoff, K.
    Nusch, A.
    Soeling, U.
    Hansen, R.
    Salat, C.
    Grebhardt, S.
    Harde, J.
    Marschner, N.
    ANNALS OF ONCOLOGY, 2017, 28
  • [47] Cetuximab plus FOLFIRI first line in patients (pts) with metastatic colorectal cancer (mCRC): A quality-of-life (QoL) analysis of the CRYSTAL trial
    Folprecht, G.
    Nowacki, M.
    Lang, I.
    Cascinu, S.
    Shchepotin, I.
    Maurel, J.
    Rougier, P.
    Cunningham, D.
    Zubel, A.
    Van Cutsem, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [48] Impact of KRAS mutational status and primary tumor location on the efficacy of aflibercept plus FOLFIRI in Japanese patients with metastatic colorectal cancer: An exploratory analysis in a phase II study
    Yamazaki, K.
    Satoh, T.
    Komatsu, Y.
    Taguchi, T.
    Sunaga, Y.
    Yoshino, T.
    ANNALS OF ONCOLOGY, 2017, 28
  • [49] First subgroup interim analysis of German patients from a global non-interventional study in metastatic renal cell carcinoma patients treated with sorafenib - the PREDICT study
    Jaeger, D.
    Brehmer, B.
    Stauch, K.
    Yu, J.
    ONKOLOGIE, 2010, 33 : 106 - 106
  • [50] Physical function and quality of life in frail and/or elderly patients with metastatic colorectal cancer treated with capecitabine and bevacizumab: An exploratory analysis
    Ward, Peter
    Hecht, J. Randolph
    Wang, He-Jing
    Dichmann, Richard
    Liem, Andre K. D.
    Chan, David
    Patel, Ravi
    Hu, Edward H. L.
    Tchekmedyian, Neres S.
    Wainberg, Zev A.
    Naeim, Arash
    JOURNAL OF GERIATRIC ONCOLOGY, 2014, 5 (04) : 368 - 375
12345